BIOMX INC (PHGE)

US09090D1037 - Common Stock

0.45  +0.09 (+26.37%)

After market: 0.4101 -0.04 (-8.87%)

Fundamental Rating

1

Taking everything into account, PHGE scores 1 out of 10 in our fundamental rating. PHGE was compared to 592 industry peers in the Biotechnology industry. Both the profitability and financial health of PHGE have multiple concerns. PHGE does not seem to be growing, but still is valued expensively.



0

1. Profitability

1.1 Basic Checks

PHGE had negative earnings in the past year.
PHGE had a negative operating cash flow in the past year.
In the past 5 years PHGE reported 4 times negative net income.
PHGE had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -80.37%, PHGE is doing worse than 73.47% of the companies in the same industry.
PHGE's Return On Equity of -326.01% is on the low side compared to the rest of the industry. PHGE is outperformed by 77.21% of its industry peers.
Industry RankSector Rank
ROA -80.37%
ROE -326.01%
ROIC N/A
ROA(3y)-50.47%
ROA(5y)-30.19%
ROE(3y)-87.72%
ROE(5y)-52.53%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

PHGE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

PHGE has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, PHGE has a worse debt to assets ratio.

2.2 Solvency

PHGE has an Altman-Z score of -8.38. This is a bad value and indicates that PHGE is not financially healthy and even has some risk of bankruptcy.
PHGE's Altman-Z score of -8.38 is on the low side compared to the rest of the industry. PHGE is outperformed by 75.68% of its industry peers.
PHGE has a Debt/Equity ratio of 0.84. This is a neutral value indicating PHGE is somewhat dependend on debt financing.
The Debt to Equity ratio of PHGE (0.84) is worse than 78.06% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF N/A
Altman-Z -8.38
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 1.98 indicates that PHGE should not have too much problems paying its short term obligations.
With a Current ratio value of 1.98, PHGE is not doing good in the industry: 79.25% of the companies in the same industry are doing better.
PHGE has a Quick Ratio of 1.98. This is a normal value and indicates that PHGE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.98, PHGE is doing worse than 77.38% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.98
Quick Ratio 1.98

1

3. Growth

3.1 Past

PHGE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 42.86%, which is quite impressive.
EPS 1Y (TTM)42.86%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q43.48%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Revenue growth Q2QN/A

3.2 Future

The Earnings Per Share is expected to grow by 12.87% on average over the next years. This is quite good.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y47.91%
EPS Next 2Y25.35%
EPS Next 3Y19%
EPS Next 5Y12.87%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

PHGE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PHGE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as PHGE's earnings are expected to grow with 19.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.35%
EPS Next 3Y19%

0

5. Dividend

5.1 Amount

No dividends for PHGE!.
Industry RankSector Rank
Dividend Yield N/A

BIOMX INC

NYSEARCA:PHGE (3/28/2024, 8:04:01 PM)

After market: 0.4101 -0.04 (-8.87%)

0.45

+0.09 (+26.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap20.73M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -80.37%
ROE -326.01%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.98
Quick Ratio 1.98
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)42.86%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y47.91%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y